# UBE2E1 Is Preferentially Expressed in the Cytoplasm of Slow-Twitch Fibers and Protects Skeletal Muscles from Exacerbated Atrophy upon Dexamethasone Treatment
(vol 7, 214, 2018)

Cécile Polge, Julien Aniort, Andrea Armani, Agnes Claustre, Cécile Coudy-Gandilhon, Clara Tournebize, Christiane Deval, Lydie Combaret, Daniel Bechet, Marco Sandri, et al.

<figure><img src="image_1.png" /></figure>

► To cite this version:

Cécile Polge, Julien Aniort, Andrea Armani, Agnes Claustre, Cécile Coudy-Gandilhon, et al.. UBE2E1 Is Preferentially Expressed in the Cytoplasm of Slow-Twitch Fibers and Protects Skeletal Muscles from Exacerbated Atrophy upon Dexamethasone Treatment (vol 7, 214, 2018). Cells, 2018, 7 (12), 10.3390/cells7120242. [hal-02622197](https://hal.inrae.fr/hal-02622197)

HAL Id: hal-02622197

https://hal.inrae.fr/hal-02622197

Submitted on 26 May 2020

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
Erratum

Erratum: Polge, C., et al. UBE2E1 Is Preferentially Expressed in the Cytoplasm of Slow-Twitch Fibers and Protects Skeletal Muscles from Exacerbated Atrophy upon Dexamethasone Treatment. *Cells* 2018, *7*, 214

Cécile Polge<fnref n="1" />, Julien Aniort<fnref n="1" />, Andrea Armani<fnref n="2" />, Agnès Claustre<fnref n="1" />, Cécile Coudy-Gandilhon<fnref n="1" />, Clara Tournebize<fnref n="1" />, Christiane Deval<fnref n="1" />, Lydie Combaret<fnref n="1" />, Daniel Béchet<fnref n="1" />, Marco Sandri<fnref n="2" />, Didier Attaix<fnref n="1" /> and Daniel Taillandier<fnref n="1" />,*

Received: 29 November 2018; Accepted: 30 November 2018; Published: 4 December 2018

<figure><img src="image_3.png" /></figure>

check for
updates

Change in author names (order).

The authors wish to make the following corrections to this paper [1]:

Cécile Polge<fnref n="1" />, Julien Aniort<fnref n="1" />, Andrea Armani<fnref n="2" />, Agnès Claustre<fnref n="1" />, Cécile Coudy-Gandilhon<fnref n="1" />, Clara Tournebize<fnref n="1" />, Christiane Deval<fnref n="1" />, Lydie Combaret<fnref n="1" />, Daniel Béchet<fnref n="1" />, Marco Sandri<fnref n="2" />, Didier Attaix<fnref n="1" /> and Daniel Taillandier<fnref n="1" />,*

The authors would like to apologize for any inconvenience caused to the readers by these changes.
The changes do not affect the scientific results.

References

1. Polge, C.; Aniort, J.; Armani, A.; Claustre, A.; Coudy-Gandilhon, C.; Tournebize, C.; Deval, C.; Combaret, L.; Béchet, D.; Sandri, M.; et al. UBE2E1 Is Preferentially Expressed in the Cytoplasm of Slow-Twitch Fibers and Protects Skeletal Muscles from Exacerbated Atrophy upon Dexamethasone Treatment. *Cells* 2018, *7*, 214.

<figure><img src="image_4.png" /></figure>

© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

<footnote n="1">¹ INRA, UMR 1019, Human Nutrition Unit (UNH), 63122 St Genès Champanelle, France; cecile.polge@inra.fr (C.P.); j.aniort@orange.fr (J.A.); agnes.claustre@inra.fr (A.C.); cecile.coudy-gandilhon@inra.fr (C.C.-G.); clara.tournebize@gmail.com (C.T.); christiane.deval@inra.fr (C.D.); lydie.combaret@inra.fr (L.C.); daniel.bechet@inra.fr (D.B.); didier.attaix@inra.fr (D.A.)</footnote>

<footnote n="2">² Venetian Institute of Molecular Medicine, 35100 Padova, Italy; andre.arma88@gmail.com (A.A.); marco.sandri@unipd.it (M.S.)</footnote>

<footnote>* Correspondence: daniel.taillandier@inra.fr; Tel.: +33-473-62-48-44</footnote>

<footnote n="1">¹ INRA, UMR 1019, Human Nutrition Unit (UNH), 63122 St Genès Champanelle, France; cecile.polge@inra.fr (C.P.); j.aniort@orange.fr (J.A.); agnes.claustre@inra.fr (A.C.); cecile.coudy-gandilhon@inra.fr (C.C.-G.); clara.tournebize@gmail.com (C.T.); christiane.deval@inra.fr (C.D.); lydie.combaret@inra.fr (L.C.); daniel.bechet@inra.fr (D.B.); didier.attaix@inra.fr (D.A.)</footnote>

<footnote n="2">² Venetian Institute of Molecular Medicine, 35100 Padova, Italy; andre.arma88@gmail.com (A.A.); marco.sandri@unipd.it (M.S.)</footnote>